2020
DOI: 10.3389/fonc.2020.00471
|View full text |Cite
|
Sign up to set email alerts
|

Lingual Lymph Node Metastasis in cT1-2N0 Tongue Squamous Cell Carcinoma: Is It an Indicator for Elective Neck Dissection

Abstract: Objective: Accurate predictors for occult metastasis in cT1-2N0 tongue squamous cell carcinoma (SCC) remains scarce, the main goal in current study was to evaluate whether there is significant association between lingual lymph node (LLN) metastasis and occult lymph node metastasis as well as whether there is prognostic value of LLN metastasis in early stage tongue SCC. Methods: Patients with surgically treated primary cT1-2N0 tongue SCC were prospectively enrolled from January 2010 to December 2018. LLNs were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 35 publications
(43 reference statements)
1
9
0
Order By: Relevance
“…Furthermore (79.3%) of the patients in this study were found to have it while only (18.8%) of them were clear of any pathologic lymph nodes, in closely similar findings to Nootan Kumar Shukla who found that (56.4%) of the patients in his study had positive pathologic lymph nodes with the rest being clear of it [17], in contrast to Tao Zbang et al who found that only (9.2%) of the patients in his study had positive pathologic lymphnodes [27]. Concerning the adjuvant therapy (50.7%) did not have any type of adjuvant therapy, (21.7%) had radiotherapy and only (1.4%) had chemotherapy, in agreement to Wenli Yang et al who found that (68.5%) of the patients in their study did not undergo adjuvant therapy with only (31.5%) of them having to go through with it [28], in contrast to Nootan Kumar Shukla et al who found that (78.5%) of the patients in their study had adjuvant therapy with the rest of them were not advised to have adjuvant therapy [17]. About the site of recurrence (44.9%) of the patients in this study did not experience recurrence, (4.3%) had local recurrence, and only (1.4%) of the patients had locoregional recurrence, in closely similar findings to Nootan Kumar Shukla et al who found that only (8.8% and 10.4%) of the patients in his study experienced local and regional recurrences respectively [17], in contrast to Jeffrey C et al who found that (63%) of the patients in his study experienced local recurrence [29].…”
Section: Discussionsupporting
confidence: 80%
“…Furthermore (79.3%) of the patients in this study were found to have it while only (18.8%) of them were clear of any pathologic lymph nodes, in closely similar findings to Nootan Kumar Shukla who found that (56.4%) of the patients in his study had positive pathologic lymph nodes with the rest being clear of it [17], in contrast to Tao Zbang et al who found that only (9.2%) of the patients in his study had positive pathologic lymphnodes [27]. Concerning the adjuvant therapy (50.7%) did not have any type of adjuvant therapy, (21.7%) had radiotherapy and only (1.4%) had chemotherapy, in agreement to Wenli Yang et al who found that (68.5%) of the patients in their study did not undergo adjuvant therapy with only (31.5%) of them having to go through with it [28], in contrast to Nootan Kumar Shukla et al who found that (78.5%) of the patients in their study had adjuvant therapy with the rest of them were not advised to have adjuvant therapy [17]. About the site of recurrence (44.9%) of the patients in this study did not experience recurrence, (4.3%) had local recurrence, and only (1.4%) of the patients had locoregional recurrence, in closely similar findings to Nootan Kumar Shukla et al who found that only (8.8% and 10.4%) of the patients in his study experienced local and regional recurrences respectively [17], in contrast to Jeffrey C et al who found that (63%) of the patients in his study experienced local recurrence [29].…”
Section: Discussionsupporting
confidence: 80%
“…In this study, however, pretreatment NLR was not significantly different between LLN-positive and LLN-negative patients. Pretreatment NLR may be a non-specific parameter because it could be influenced by concomitant conditions, such as infections or inflammation [ 17 ]. In the current study, multivariate analysis revealed clinical neck node metastasis as an independent risk factor of LLN metastasis, which corresponded with previous reports [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Various references have demonstrated the role of histopathologic parameters of the primary tumor, such as tumor size [25][26][27], DOI [25,26,28], tumor thickness [25,27,28], differentiation grade [25,26], perivascular/perineural invasion [27,29] as possible predictors of occult neck metastasis. Our study confirms the role of tumor size, differentiation grade and perivascular/perineural invasion in accurately staging the clinically negative neck in early-stage OSCC of the tongue.…”
Section: Discussionmentioning
confidence: 99%